BORGOGNA, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 2.223
EU - Europa 2.108
AS - Asia 1.706
SA - Sud America 276
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 44
OC - Oceania 5
Totale 6.447
Nazione #
US - Stati Uniti d'America 2.157
SG - Singapore 588
RU - Federazione Russa 543
CN - Cina 377
IE - Irlanda 329
DE - Germania 300
VN - Vietnam 278
IT - Italia 243
BR - Brasile 218
HK - Hong Kong 214
SE - Svezia 196
UA - Ucraina 139
FR - Francia 110
FI - Finlandia 66
IN - India 60
GB - Regno Unito 55
KR - Corea 49
CA - Canada 37
BD - Bangladesh 35
CZ - Repubblica Ceca 31
MX - Messico 24
TR - Turchia 24
AR - Argentina 20
ID - Indonesia 18
ES - Italia 16
ZA - Sudafrica 16
AT - Austria 15
NL - Olanda 15
BE - Belgio 14
PL - Polonia 14
BJ - Benin 13
CO - Colombia 12
IR - Iran 11
JP - Giappone 8
EC - Ecuador 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
PK - Pakistan 6
CL - Cile 5
LT - Lituania 5
PE - Perù 5
SA - Arabia Saudita 5
TH - Thailandia 4
AU - Australia 3
HR - Croazia 3
LV - Lettonia 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MR - Mauritania 2
SR - Suriname 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NR - Nauru 1
OM - Oman 1
PW - Palau 1
SI - Slovenia 1
VE - Venezuela 1
YE - Yemen 1
Totale 6.364
Città #
Dublin 327
San Jose 237
Jacksonville 229
Hong Kong 214
Singapore 155
Dearborn 146
Chandler 134
Beijing 124
Council Bluffs 112
Ashburn 107
Los Angeles 91
Ho Chi Minh City 89
Columbus 63
Ann Arbor 59
Hanoi 54
Moscow 51
Wilmington 49
Seoul 45
Lauterbourg 44
Lawrence 43
Princeton 43
Munich 42
New York 42
Piemonte 39
San Mateo 36
Brno 31
Novara 30
Santa Clara 29
Bremen 24
Frankfurt am Main 24
São Paulo 24
Buffalo 23
Milan 19
Orem 19
Haiphong 17
Toronto 17
Genoa 16
Dallas 15
Düsseldorf 15
Nuremberg 15
Andover 14
Brussels 14
Chennai 14
Helsinki 14
Boardman 13
Cotonou 13
Guangzhou 13
Houston 13
Da Nang 12
London 12
Redondo Beach 12
Turin 12
Amsterdam 11
Denver 11
Grafing 11
Hefei 11
Johannesburg 11
Tianjin 11
Warsaw 11
Woodbridge 11
Nanjing 10
Rome 10
Atlanta 9
Brooklyn 9
Jakarta 9
Dong Ket 8
Mexico City 8
Montreal 8
Poplar 8
Rio de Janeiro 8
Chicago 7
Hangzhou 7
Manchester 7
Monmouth Junction 7
Nanchang 7
Phoenix 7
Tokyo 7
Biên Hòa 6
Boston 6
Can Tho 6
Kunming 6
Leawood 6
Mumbai 6
Norwalk 6
Querétaro 6
San Francisco 6
Turku 6
Buenos Aires 5
Fairfield 5
Falkenstein 5
Medellín 5
Miami 5
Paris 5
Seattle 5
Tornaco 5
Vienna 5
Zhengzhou 5
Ankara 4
Ardabil 4
Augusta 4
Totale 3.395
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 282
HPV E7 Oncoprotein Subverts Host Innate Immunity Via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes 191
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling 183
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 176
β-HPV Infection Correlates with Early Stages of Carcinogenesis in Skin Tumors and Patient-Derived Xenografts from a Single Center Kidney Transplant Recipient Cohort 166
Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells. 151
Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases 150
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution 143
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 142
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models 140
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 138
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion 137
Characterization of skin lesions induced by skin-tropic α- and β-papillomaviruses in a patient with epidermodysplasia verruciformis 136
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 136
Alpha- and Beta-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions. 136
Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients. 134
HPV-induced field cancerisation: Transformation of adult tissue stem cell into cancer stem cell 132
Primary trichodysplasia spinulosa polyomavirus infection in a kidney transplant child displaying virus-infected decoy cells in the urine 131
Identification of the skin virome in a young boy with widespread HPV2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine 129
Evidence of BK Polyomavirus Infection in Urothelial but not Renal Tumors from a Single Center Cohort of Kidney Transplant Recipients 128
TRICHODYSPLASIA SPINULOSA IN A KIDNEY TRANSPLANT RECIPIENT WITH CONCURRENT JC, BK, AND TSPYV VIRURIA AND DECOY OR DEGENERATED CELLS 126
Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties. 125
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story 125
Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene 124
The nuclear DNA sensor IFN-inducible protein 16 (IFI16) acts as restriction factor for human papillomavirus replication 123
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 122
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 119
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 117
Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations 116
Restriction of HPV18 Replication in the Nucleus by IFI16: what about Innate Sensing? 116
HumanBeta-papillomavirus infection and keratinocyte carcinomas 115
Metagenomic discovery of 83 new human papillomavirus types in patients with immunodeficiency 114
Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING 113
SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy 111
A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine 111
Cancer-Associated Fibroblasts Exert Proangiogenic Activity in Merkel Cell Carcinoma 108
#Stayathome If You Have a Cold: High SARS-CoV-2 Salivary Viral Loads in Pediatric Patients with Nasopharyngeal Symptoms 108
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study 107
Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of auto antigen processing. BORGOGNA C. CO-FIRST AUTHOR 95
The intracellular DNA sensor IFI16 gene acts as a restriction factor for human papillomavirus replication 94
Keratinocyte-Specific Stat3 Heterozygosity Impairs Development of Skin Tumors in Human Papillomavirus 8 Transgenic Mice 93
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles 92
No indications for HPV involvement in the hypertrophic skin lesions of a Darier disease case without ATP2A2 gene mutations 91
The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 90
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 88
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. 87
Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed Human Papillomavirus Type 8‒Transgenic Mice 85
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity 83
Longitudinal monitoring of SARS-CoV-2 viral load in self-collected saliva from health care workers during breakthrough infections to spare working days 81
Identification of Defective Fas Function and Variation of the Perforin Gene in an Epidermodysplasia Verruciformis Patient Lacking EVER1 and EVER2 Mutations 81
HPV8-induced STAT3 activation led keratinocyte stem cell expansion in human actinic keratoses 78
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16 72
Convergent evolution of the G3BP1-binding motif in betacoronavirus nucleocapsid proteins 56
IFI16 restricts SARS-CoV-2 replication by disrupting nucleocapsid-driven phase separation 20
Totale 6.447
Categoria #
all - tutte 28.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022347 0 18 41 42 16 5 23 13 16 22 56 95
2022/2023833 48 37 63 14 63 87 22 65 368 4 28 34
2023/2024396 39 21 29 7 37 8 90 7 2 7 89 60
2024/2025900 31 11 39 19 55 18 60 77 176 57 115 242
2025/20262.654 139 125 204 425 212 174 364 414 179 199 159 60
2026/2027229 93 136 0 0 0 0 0 0 0 0 0 0
Totale 6.447